KRKA, d.d., Novo Mesto (responsible for full manufacturing cycle, including batch release)/KRKA, d.d., Novo Mesto (responsible for batch control)
UkraineAll drugs from this manufacturer
-
The drug is prescribed for the treatment of bacterial infections, including acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs (under certain conditions).
Dosage form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14